
The March 2008 issue of Institutional Investor magazine lists Jeff Edwards, Allergan’s Chief Financial Officer (CFO), as America’s best CFO in the Health Care – Pharmaceuticals/Specialty category. The results are based on the responses of 675 investment professionals at 350 of the world’s most influential money management firms. More can be read about the America's Best CFOs 2008 Survey on the Institutional Investor magazine Web site:
Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential to see more clearly, move more freely, express themselves more fully.
Our focus fosters deep engagement with medical specialists and we make it our business to listen closely to their needs so that together we can advance patient care. We combine this strategic focus with a diversified approach that enables us to follow our research and development into new specialty areas where unmet needs are significant.
In partnership with the medical community, we bring scientific excellence and rigor to deliver leading products that improve patient outcomes. And, we go above and beyond this to provide education and information, with the highest level of integrity, that helps patients to fully understand the choices available to them and make well-informed treatment decisions with their doctors. We know we are successful when doctors and patients place their trust in our products and our company, when our employees excel and when our efforts make a meaningful difference in the lives of the patients and communities we serve.
We are pleased to offer a number of leading products, including: BOTOX® (Botulinum Toxin Type A), RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, LUMIGAN® (bimatoprost ophthalmic solution) 0.03%, BOTOX® Cosmetic (Botulinum Toxin Type A), the JUVÉDERM™ family of dermal fillers, and the LAP-BAND® Adjustable Gastric Banding System. Throughout our Web site you can learn more about these and our full portfolio of products.